Transforming growth factor-β(TGF-β) is a key factor in cancer development and progression. TGF-β can suppress tumorigenesis by inhibiting cell cycle progression and stimulating apoptosis in early stages of cancer p...Transforming growth factor-β(TGF-β) is a key factor in cancer development and progression. TGF-β can suppress tumorigenesis by inhibiting cell cycle progression and stimulating apoptosis in early stages of cancer progression. However, TGF-β can modulate cancer-related processes, such as cell invasion, distant metastasis, and microenvironment modification that may be used by cancer cells to their advantage in late stages. Corresponding mechanisms include angiogenesis promotion, anti-tumor immunity suppression, and epithelial-to-mesenchymal transition(EMT) induction. The correlation between TGF-β expression and cancer prognosis has also been extensively investigated. Results suggest that TGF-β pathway can be targeted to treat cancer; as such, the feasibility of this treatment is investigated in clinical trials.展开更多
目的:探讨解整合素金属蛋白酶17(a disintegrin and metalloproteinase-17,ADAM17)在人胰腺癌细胞株中的表达及其对细胞增殖迁移的影响。方法:利用实时定量PCR法和蛋白质印迹法检测3种人胰腺癌细胞株内ADAM17mRNA和蛋白的表达水平。构...目的:探讨解整合素金属蛋白酶17(a disintegrin and metalloproteinase-17,ADAM17)在人胰腺癌细胞株中的表达及其对细胞增殖迁移的影响。方法:利用实时定量PCR法和蛋白质印迹法检测3种人胰腺癌细胞株内ADAM17mRNA和蛋白的表达水平。构建可诱导表达ADAM17-shRNA的慢病毒载体,转染人胰腺癌细胞株,并筛选出稳定转染的克隆细胞株。在不同浓度(0,30μg/m L)的多西环素诱导ADAM17-shRNA表达后,通过CCK-8法和细胞划痕实验检测人胰腺癌细胞的体外增殖、迁移能力。结果:ADAM17 mRNA及蛋白在人胰腺癌细胞株PANC1、SW1990和Patu8988中均有表达。与未诱导表达ADAM17-shRNA的对照组相比,诱导表达特异性ADAM17-shRNA后,细胞ADAM17蛋白表达和体外增殖、迁移能力均受到明显抑制(均P<0.05)。结论:ADAM17在人胰腺癌细胞中高表达,在其增殖、迁移过程中可能发挥重要作用。展开更多
AIM: To evaluate the significance of transforming growth factor beta (TGF β) expression, in correlation with histopathological parameters, at the front of invasion in T1 colorectal cancer (CRC) and presence of metast...AIM: To evaluate the significance of transforming growth factor beta (TGF β) expression, in correlation with histopathological parameters, at the front of invasion in T1 colorectal cancer (CRC) and presence of metastases. METHODS: TGF p immunohistochemical expression was studied in 34 specimens of colorectal adenocarcinomas (pT1). A three-step avidin-biotinylated immuno-peroxidase (ABCu-NCL) staining technique was performed on 4-μm paraffin-embedded tissue sections with a monoclonal antibody to TGF β (Novocastra, NCL-TGFB, clone TGFB 17, dilution 1:40). RESULTS: Seventeen (50%) out of 34 lesions were positive for TGF p expression. The TGF β-positive rate in patients with vascular invasion was significantly higher than in those without vascular invasion (11/14 cases, P<0.01, P= 0.005). The TGF p-positive rate was observed in 91.7% of patients with presence of tumor budding at the front of invasion (11/12 cases, P<0.01, P= 0.0003). A statistically significant correlation was found between the presence of lymph node metastases and positive expression of TGF β (14/16 cases, P<0.01, P= 0.0001). We also observed that the TGF β-positive rates in groups with distant and non-distant metastases were 92.8% and 20% respectively, and a significant correlation between TGF β expression and distant metastasis was shown (P<0.01, P= 0.00003). CONCLUSION: The evaluation of TGF β expression of protein in association with histological parameters can be used as a parameter of the aggressiveness of pT1 CRC.展开更多
The tumor-promoting arm of transforming growth factor beta(TGF-β)receptor signaling contributes to advanced cancer progression and is considered a master regulator of breast cancer metastasis.In mammals,there are six...The tumor-promoting arm of transforming growth factor beta(TGF-β)receptor signaling contributes to advanced cancer progression and is considered a master regulator of breast cancer metastasis.In mammals,there are six distinct members in the tumor-necrosis factor receptor(TNFR)-associated factor(TRAF)family(TRAF1–TRAF6),with the function of TRAF4 not being extensively studied in the past decade.Although numerous studies have suggested that there is elevated TRAF4 expression in human cancer,it is still unknown in which oncogenic pathway TRAF4 is mainly implicated.This review highlights TGF-β-induced SMAD-dependent signaling and non-SMAD signaling as the major pathways regulated by TRAF4 involved in breast cancer metastasis.展开更多
在发育过程中神经元前体细胞的外向迁移对于大脑皮层的多层结构建立有着重要作用.金属蛋白酶家族的成员ADAM17(A Disintegrin And Metalloprotease 17)对于多种膜蛋白的成熟释放有着重要作用,包括多个表皮生长因子受体的配体以及Notch...在发育过程中神经元前体细胞的外向迁移对于大脑皮层的多层结构建立有着重要作用.金属蛋白酶家族的成员ADAM17(A Disintegrin And Metalloprotease 17)对于多种膜蛋白的成熟释放有着重要作用,包括多个表皮生长因子受体的配体以及Notch等蛋白.这些底物中有多个对神经干细胞的增殖、分化、迁移都有重要作用.为了探讨ADAM17在大脑皮层发育过程中的生理作用,结合RNAi和IUE的技术,降低小鼠大脑发育阶段中ADAM17的表达.结果显示:用RNAi降低ADAM17在小鼠大脑皮层发育14—18d中的表达,会造成神经元前体细胞的外向迁移障碍,使得细胞停留在脑室下区.展开更多
基金supported by the National Natural Science Foundation of China (Grant No. 81372429)
文摘Transforming growth factor-β(TGF-β) is a key factor in cancer development and progression. TGF-β can suppress tumorigenesis by inhibiting cell cycle progression and stimulating apoptosis in early stages of cancer progression. However, TGF-β can modulate cancer-related processes, such as cell invasion, distant metastasis, and microenvironment modification that may be used by cancer cells to their advantage in late stages. Corresponding mechanisms include angiogenesis promotion, anti-tumor immunity suppression, and epithelial-to-mesenchymal transition(EMT) induction. The correlation between TGF-β expression and cancer prognosis has also been extensively investigated. Results suggest that TGF-β pathway can be targeted to treat cancer; as such, the feasibility of this treatment is investigated in clinical trials.
文摘AIM: To evaluate the significance of transforming growth factor beta (TGF β) expression, in correlation with histopathological parameters, at the front of invasion in T1 colorectal cancer (CRC) and presence of metastases. METHODS: TGF p immunohistochemical expression was studied in 34 specimens of colorectal adenocarcinomas (pT1). A three-step avidin-biotinylated immuno-peroxidase (ABCu-NCL) staining technique was performed on 4-μm paraffin-embedded tissue sections with a monoclonal antibody to TGF β (Novocastra, NCL-TGFB, clone TGFB 17, dilution 1:40). RESULTS: Seventeen (50%) out of 34 lesions were positive for TGF p expression. The TGF β-positive rate in patients with vascular invasion was significantly higher than in those without vascular invasion (11/14 cases, P<0.01, P= 0.005). The TGF p-positive rate was observed in 91.7% of patients with presence of tumor budding at the front of invasion (11/12 cases, P<0.01, P= 0.0003). A statistically significant correlation was found between the presence of lymph node metastases and positive expression of TGF β (14/16 cases, P<0.01, P= 0.0001). We also observed that the TGF β-positive rates in groups with distant and non-distant metastases were 92.8% and 20% respectively, and a significant correlation between TGF β expression and distant metastasis was shown (P<0.01, P= 0.00003). CONCLUSION: The evaluation of TGF β expression of protein in association with histological parameters can be used as a parameter of the aggressiveness of pT1 CRC.
基金supported by the Zhejiang University Special Fund for Fundamental Researchthe Fundamental Research Funds for the Central Universities(R14C070002)the Netherlands Organization of Scientific Research grant(MW-NWO 918.66.606),from the Cancer Genomics Centre Netherlands and the Centre for Biomedical Genetics
文摘The tumor-promoting arm of transforming growth factor beta(TGF-β)receptor signaling contributes to advanced cancer progression and is considered a master regulator of breast cancer metastasis.In mammals,there are six distinct members in the tumor-necrosis factor receptor(TNFR)-associated factor(TRAF)family(TRAF1–TRAF6),with the function of TRAF4 not being extensively studied in the past decade.Although numerous studies have suggested that there is elevated TRAF4 expression in human cancer,it is still unknown in which oncogenic pathway TRAF4 is mainly implicated.This review highlights TGF-β-induced SMAD-dependent signaling and non-SMAD signaling as the major pathways regulated by TRAF4 involved in breast cancer metastasis.
文摘在发育过程中神经元前体细胞的外向迁移对于大脑皮层的多层结构建立有着重要作用.金属蛋白酶家族的成员ADAM17(A Disintegrin And Metalloprotease 17)对于多种膜蛋白的成熟释放有着重要作用,包括多个表皮生长因子受体的配体以及Notch等蛋白.这些底物中有多个对神经干细胞的增殖、分化、迁移都有重要作用.为了探讨ADAM17在大脑皮层发育过程中的生理作用,结合RNAi和IUE的技术,降低小鼠大脑发育阶段中ADAM17的表达.结果显示:用RNAi降低ADAM17在小鼠大脑皮层发育14—18d中的表达,会造成神经元前体细胞的外向迁移障碍,使得细胞停留在脑室下区.
